Displaying 19 - 36 of 167
20 Sep 2022
ARPANSA’s Australian Clinical Dosimetry Service (ACDS) has carried out its first live stereotactic radiosurgery (SRS) audit which supports dose accuracy in radiation therapy used to treat brain cancer.
15 Sep 2022
The Australian Radiation Protection and Nuclear Safety Agency (ARPANSA) is pleased to announce the launch of their new website.
24 Aug 2022
Addressing human and organisational factors that impact nuclear safety is among the changes to the 2018 Australian Radiation Protection and Nuclear Safety (ARPANSA) Regulations that came into effect on 10 August 2022.
2 Aug 2022
Scientists from the Australian Radiation Protection and Nuclear Safety Agency (ARPANSA) will be countering misinformation about radio waves as part of National Science Week at a free event at the Science Gallery, University of Melbourne on 17 August 2022.
20 Jul 2022
The Australian Radiation Protection and Nuclear Safety Agency (ARPANSA) and ANSTO have coordinated with the IAEA to donate radiation measurement and personal protective equipment to Ukraine.
13 Jul 2022
Exposing humans to ultraviolet radiation to test sunscreen effectiveness should be phased out, according to scientists and cancer experts.
4 Jul 2022
Calculating exposure from naturally occurring radioactive material (NORM) has been standardised by the Australian Radiation Protection and Nuclear Safety Agency to encourage national uniformity and ongoing alignment with international best practice.
21 Jun 2022
ARPANSA has teamed up with Cancer Council Victoria and the Australian Bureau of Meteorology to create a SunSmart Global UV app.
15 Jun 2022
ARPANSA has released an advisory note on the public health considerations for disposal of radioactive waste.
30 May 2022
ARPANSA holds its annual licence holders forum
11 May 2022
ARPANSA is working with the International Atomic Energy Agency (IAEA) and dosimetry auditors globally to develop a world first film dosimetry intercomparison tool.
2 May 2022
Illegal laser pointers that are being imported into the country due to incorrect product labelling is an issue being pinpointed to Australia’s Freight and Trade Alliance this month by ARPANSA scientist Dr Chris Brzozek.
2 May 2022
Recruitment is currently underway for the next Chief Radiation Health Scientist and Head of Radiation Health Services Branch of ARPANSA.
21 Apr 2022
ARPANSA has provided funding to RMIT to investigate the impact of non-ionising radiation on cell permeability. This research is funded as the first ‘major project’ under ARPANSA’s new EME Program Research Framework.
30 Mar 2022
ARPANSA experts have published an article in Public Health Research and Practice, a journal of the Sax Institute, that calls for more research into the use of non-ionising radiation for cosmetic purposes.
18 Mar 2022
The Australian Government announces the appointment of Dr Gillian Hirth as Chief Executive Officer (CEO) of ARPANSA following the retirement of current CEO, Dr Carl-Magnus Larsson.
15 Mar 2022
ARPANSA has issued a licence to the Australian Nuclear Science and Technology Organisation (ANSTO) to prepare a site for the Intermediate Level Waste Capacity Increase (ILWCI) facility.
9 Mar 2022
A review led by ARPANSA has shown that sunscreen is safe to use and, when applied correctly, reduces the risk of skin cancer and sunburn.
